Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.385
+0.085 (2.60%)
Sep 13, 2024, 10:39 AM EDT - Market open
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $245.72 million as of September 13, 2024. Its market cap has increased by 66.59% in one year.
Market Cap
245.72M
Enterprise Value
171.25M
1-Year Change
66.59%
Ranking
Category
Stock Price
$3.39
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $140.20M to $245.72M, an increase of 75.27%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2024 | 239.60M | 179.91% |
| Dec 29, 2023 | 85.60M | -26.02% |
| Dec 30, 2022 | 115.70M | 472.77% |
| Dec 31, 2021 | 20.20M | -54.61% |
| Dec 31, 2020 | 44.50M | -33.48% |
| Dec 31, 2019 | 66.90M | -52.28% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zynex | 251.08M |
| Abeona Therapeutics | 242.13M |
| Alpha Teknova | 241.46M |
| 2seventy bio | 240.75M |
| Amarin Corporation | 239.63M |
| Nanobiotix | 237.49M |
| MacroGenics | 233.25M |
| Nektar Therapeutics | 232.86M |